Prostate Cancer - Results from #20

ATAD2 Drives Prostate Cancer Progression to Metastasis. February 10, 2025

Implementing and Optimizing Universal Germline Genetic Testing for Patients with Prostate Cancer in Clinical Practice Consider. February 10, 2025

Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth. February 10, 2025

MR-guided Transrectal Focal Laser Ablation for Localized Low- and Intermediate Risk Prostate Cancer: Initial Outcomes Using an Integrated Laser Ablation System. February 10, 2025

Long-term outcomes of LDR-brachytherapy for localized prostate cancer. February 10, 2025

Associations between socioeconomic factors and PSA testing in a population-based organised testing programme and routine healthcare: a register-based study of 50-year-old men. February 10, 2025

Omission of Contralateral Systematic Biopsies in Unilateral Suspicious Prostate Cancer on Magnetic Resonance Imaging: Implications for Radiation Treatment Selection. February 10, 2025

Utility of 18F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomy. February 10, 2025

New rectum dose surface mapping methodology to identify rectal subregions associated with toxicities following prostate cancer radiotherapy. February 10, 2025

Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy. February 10, 2025

Monitoring of prostate cancer screening in the European Union: development of key performance indicators through the PRAISE-U project. February 10, 2025

Impact of Prebiopsy Multiparametric Magnetic Resonance Imaging on Prostate Cancer Detection in Switzerland. February 10, 2025

Trends in outpatient radical prostatectomy and same day discharge for prostate cancer: Analysis of the National Inpatient Sample and Nationwide Ambulatory Surgery Sample. February 7, 2025

Enzalutamide and Docetaxel in Combination With Androgen Deprivation for Men With Metastatic Hormone-Sensitive Prostate Cancer: ENZADA, a Phase II Trial. February 7, 2025

The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update. February 7, 2025

Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC. February 7, 2025

Targeting AXL inhibits the growth and metastasis of prostate cancer in bone. February 7, 2025

Incisional PSMA PET/CT-positive recurrences in prostate cancer- is there an implication on clinical care? February 7, 2025

Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy. February 6, 2025

Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials. February 6, 2025

Page 2 of 1458